Vera Therapeutics appointed Amgen and Seagen alum Matt Skelton as EVP of commercial. Frank Lane was appointed SVP and head of ...

Geron Corporation's Rytelo gains FDA approval for MDS treatment, with promising sales and positive analyst outlook. Click ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...

Operator instructions] I would now like to turn the conference over to Aron Feingold, vice president of investor relations ...

H.C. Wainwright initiated coverage of Geron (NASDAQ:GERN) with a buy rating, citing the potential of its recently approved ...

Shares of Geron Co. (NASDAQ:GERN – Get Free Report) have been assigned an average recommendation of “Buy” from the eleven ...

H.C. Wainwright has recently initiated Geron Corp (GERN) stock to Buy rating, as announced on November 5, 2024, according to Finviz. Earlier, on October 16, 2024, Scotiabank had initiated the stock to ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced members of the management team are scheduled to partic ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...

In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Geron (GERN – Research Report), with a price target of ...

Stifel Nicolaus analyst Stephen Willey maintained a Buy rating on Geron (GERN – Research Report) on November 8 and set a price target of ...

Geron received $250 million in gross proceeds at closing, with access to an additional $125 million in debt Strengthens balance sheet to support the commercial launch of RYTELO™ in the U.S. and ...